INDEPENDENT NEWS

Helius appoints Quality Manager

Published: Mon 14 Oct 2019 09:42 AM
Helius Therapeutics has appointed Keryn Davies as its Quality Manager. She will ensure pharmaceutical and regulatory compliance, as well as the quality of all manufactured medicinal cannabis products.
For the past 17 years Ms Davies has worked in the pharmaceutical industry, both in New Zealand and the UK. Her roles have spanned quality control, analytical and formulation development, and quality management.
As Quality Manager she will report to the Chief Science Officer at Helius Therapeutics, Dr Jim Polston. His appointment earlier this year marked the first globally-recognised medicinal cannabis researcher to move to New Zealand.
Helius Therapeutics Co-Chief Executive, Paul Manning, says as the country’s largest licensed biotechnology company focused on medicinal cannabis, the appointment of Keryn Davies is another milestone.
“It reinforces the absolute commitment by Helius to develop and deliver quality, safe cannabis-based medicines in a heavily regulated environment, that will ease the suffering of thousands of New Zealanders,” says Mr Manning.
Ms Davies is excited to be part of the emerging medicinal cannabis industry and Helius – the first certified New Zealand Grown cannabis producer.
“The cultivation and extraction facilities at Helius are second-to-none, as are the company’s cannabinoid research lab and manufacturing operations. However, what impressed me most about Helius, was their resolute commitment to ensuring New Zealanders have access to efficacious and safe cannabis products they can trust,” says Ms Davies.
Mr Manning says several other key appointments at Helius will be announced soon.
“Recruiting talent and expertise both nationally and internationally is helping us build a truly world-class therapeutics company – and a stronger medicinal cannabis industry. New Zealand has the potential to become a global centre of excellence for medicinal cannabis innovation,” he says.
Helius Therapeutics is the foundation sponsor for MedCan 2020 - New Zealand’s first international medicinal cannabis summit. BioTechNZ is hosting the day-long event on Thursday, 19 March 2020 at SkyCity Auckland Convention Centre.

Next in Business, Science, and Tech

Scientists Say Methane Emitted By Humans ‘vastly Underestimated’
By: NIWA
Record Dry Spells And Effects On Forests – Expert Reaction
By: Science Media Centre
Official Cash Rate Remains At 1.0 Percent
By: The Reserve Bank of New Zealand
Novel coronavirus detected in China –Expert Reaction
By: Science Media Centre
Flooding could release toxic gas – Expert Reaction
By: Science Media Centre
Damning New Report Says Every Nation Undermining Children
By: Common Dreams - Andrea Germanos
‘And Then - Nothing. Silence’: The Deadly Facade Of ‘Democracy’
By: MediaLens
Concentration Of CO2 Hits 416 Ppm - highest EVER daily average, but it still wont be breaking news
By: Common Dreams - Jessica Corbett
23 Former Diplomats Urge Global Leaders To Adopt Paris-Style Agreement To Protect Biodiversity
By: Common Dreams - Jessica Corbett
Greenpeace Campaigner Of 22 Years Announces Bid To Stand For Parliament
By: Steve Abel
Kiwi youth feeling the heat
By: Business NZ
How NZ would fare during a world catastrophe
By: RNZ
Antarctic continent posts record temperature
By: United Nations
Climate action ‘both a priority and a driver of the decade
By: United Nations
Public surveyed on state of the environment
By: Lincoln University
View as: DESKTOP | MOBILEWe're in BETA! Send Feedback © Scoop Media